Dyne Therapeutics officer proposes $92.8K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
144
Rhea-AI Filing Summary
John Cox, an officer of Dyne Therapeutics, Inc. (DYN), gave notice of a proposed sale of 5,513 common shares, with an aggregate market value of $92,751.00 and an approximate sale date of November 13, 2026. Stifel Nicolaus & Company Inc. is listed as the broker.
Key Figures
Proposed sale: 5,513 common shares
Aggregate market value: $92,751.00
Shares outstanding: 186,746,431 shares
+3 more
6 metrics
Proposed sale
5,513 common shares
Approximate sale date November 13, 2026
Aggregate market value
$92,751.00
For the proposed sale of common shares
Shares outstanding
186,746,431 shares
Number reported in the securities information
Restricted stock units acquired
11,250 units
Acquired from the issuer as equity compensation on November 13, 2026
Prior sale
5,658 common shares
Sale reported for September 8, 2026
Gross proceeds
$106,844.00
From the September 8, 2026 sale
Key Terms
Restricted Stock Units
1 terms
Restricted Stock Units financial
"Nature of Acquisition Transaction: Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What other securities transactions are listed for John Cox in the DYN Form 144?
The notice lists 11,250 restricted stock units acquired from the issuer as equity compensation on November 13, 2026. It also reports that John Cox sold 5,658 common shares on September 8, 2026, for gross proceeds of $106,844.00.
AI-generated analysis. How Rhea-AI works. Not financial advice.